You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

6% HES

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Edema Trial in Cairo (Thoracic fluid content estimation)

Completed
  • Pulmonary Edema
  • Thoracic fluid content estimation
  • Cairo, Manial, Egypt
    Cairo University hospitals
Mar 10, 2022

Adverse Effect Trial (Hydroxyethyl starch coload - 0 ml/kg, Hydroxyethyl starch coload - 5 ml/kg, Hydroxyethyl starch coload -

Not yet recruiting
  • Adverse Effect
  • Hydroxyethyl starch coload - 0 ml/kg
  • +2 more
  • (no location specified)
Jan 25, 2023

Postoperative Kidney Injury Trial in Cleveland (human albumin 5%, HES 130/0.4 (Voluven))

Completed
  • Postoperative Kidney Injury
  • human albumin 5%
  • HES 130/0.4 (Voluven)
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Apr 18, 2022

Hypovolaemia Due to Acute Blood Loss Trial in Worldwide (Volulyte 6%, Ionolyte)

Active, not recruiting
  • Hypovolaemia Due to Acute Blood Loss
  • Sankt Veit, Austria
  • +60 more
May 23, 2022

Endothelial Dysfunction Trial in Cleveland (Human albumin, Hydroxyethyl starch)

Completed
  • Endothelial Dysfunction
  • Human albumin
  • Hydroxyethyl starch
  • Cleveland, Ohio
    Cleveland Clinic
Jul 20, 2020

Hypereosinophilic Syndrome Trial (Depemokimab, Placebo)

Recruiting
  • Hypereosinophilic Syndrome
  • Atlanta, Georgia
  • +18 more
Feb 1, 2023

Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases

Recruiting
  • Eosinophilic Myeloid Neoplasm
  • Hypereosinophilic Syndrome
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Arterial Bleeding in Solid Organs and Peripheral Arteries Trial (Embrace HES including Instylla™ Delivery Kit and Instylla™

Recruiting
  • Arterial Bleeding in Solid Organs and Peripheral Arteries
  • Embrace HES including Instylla™ Delivery Kit and Instylla™ Microcatheter
  • Long Beach, California
  • +1 more
Dec 16, 2022

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting
Has Results
  • Respiratory System Agents
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022

Hypereosinophilia, Hypereosinophilic Syndrome Trial in Worldwide (mepolizumab)

Completed
  • Hypereosinophilia
  • Hypereosinophilic Syndrome
  • San Diego, California
  • +28 more
May 1, 2020

Heart Valve Diseases Trial in Tehran (Six percent hydroxy ethyl starch 130/0.4, Ringer lactate)

Completed
  • Heart Valve Diseases
  • Six percent hydroxy ethyl starch 130/0.4
  • Ringer lactate
  • Tehran, Iran, Islamic Republic of
    Rajaie CMRC
Jan 23, 2022

Healthy Volunteers Trial in Sha Tin, Christchurch (Diroximel fumarate)

Completed
  • Healthy Volunteers
  • Diroximel fumarate
  • Sha Tin, New Territories, Hong Kong
  • +1 more
Jul 1, 2022

Hypereosinophilic Syndrome Trial in Argentina, Spain, United States (Mepolizumab)

Recruiting
  • Hypereosinophilic Syndrome
  • Rochester, Minnesota
  • +8 more
Aug 11, 2022

Mitral Regurgitation, Mitral Stenosis, Tricuspid Regurgitation Trial in Seoul (Acute normovolemic hemodilution (ANH),

Completed
  • Mitral Regurgitation
  • +2 more
  • Acute normovolemic hemodilution (ANH)
  • hydroxyethyl starch (HES 130/0.6)
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Jan 28, 2020

LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial

Recruiting
  • Intracranial Aneurysm
  • LVIS EVO and HydroCoil Embolic System
  • Charleroi, Belgium
  • +18 more
Jun 9, 2022

Eosinophilia, Hypereosinophilic Syndrome, Leukocyte Disorder Trial run by the NIAID (prednisone)

Completed
Has Results
  • Eosinophilia
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 26, 2022

Uptake of Childhood Live Attenuated Influenza Vaccine and

Completed
  • Influenza
    • London, United Kingdom
      CPRD
    Oct 4, 2023

    Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

    Completed
    Has Results
    • Chronic Myelomonocytic Leukemia
    • +4 more
    • Imatinib Mesylate (Gleevec)
    • Houston, Texas
      UT MD Anderson Cancer Center
    Dec 7, 2021

    Hypereosinophilic Syndrome Trial in Worldwide (Benralizumab, Placebo)

    Recruiting
    • Hypereosinophilic Syndrome
    • Benralizumab
    • Placebo
    • La Jolla, California
    • +45 more
    Feb 2, 2023

    Gather Information About Rivaroxaban in United Kingdom Who Have

    Completed
    • Treatment of Venous Thromboembolism in Cancer Patients
    • Rivaroxaban (Xarelto, BAY59-7939)
    • +2 more
    • Multiple Locations, United Kingdom
      Many locations
    Sep 19, 2022

    Post-COVID-19 Syndrome Trial in Istanbul (non-invasive auricular vagus stimulation, Placebo Non Invasive Vagus Stimulation)

    Recruiting
    • Post-COVID-19 Syndrome
    • non-invasive auricular vagus stimulation
    • Placebo Non Invasive Vagus Stimulation
    • Istanbul, Istanbul Avrupa Kitasi, Turkey
      Bahçeşehir University
    Mar 10, 2023

    In Silico Trials of Surgical Interventions

    Active, not recruiting
    • Cardiovascular Diseases
      • Leicester, Leicestershire, United Kingdom
        Department of Cardiovascular Sciences, University of Leicester,
      May 9, 2023

      Total Knee Arthroplasty Trial (Low Load Strength Training under Blood Flow Restriction)

      Not yet recruiting
      • Total Knee Arthroplasty
      • Low Load Strength Training under Blood Flow Restriction
      • (no location specified)
      May 9, 2023

      GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

      Active, not recruiting
      • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
        • Durham, North Carolina
          RTI Health Solutions
        Jun 14, 2022

        Outcomes for Dilated Cardiomyopathy

        Recruiting
        • Dilated Cardiomyopathy
        • Cardiovascular Diseases
        • Part 1: DCM Cohort
        • Part 2: Heritable CV Diseases and Family Members
        • Leeds, United Kingdom
        • +5 more
        Mar 29, 2022